Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About NEUE Interactive Breakdown Better Bets vs. NEUE Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

NeueHealth (NEUE)

Market Price (10/31/2025): $6.85 | Market Cap: $61.5 Mil
Sector: Financials | Industry: Life & Health Insurance

NeueHealth (NEUE)

Market Price (10/31/2025): $6.85
Market Cap: $61.5 Mil
Sector: Financials
Industry: Life & Health Insurance

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0   Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -29 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -3.3%
1   Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 112%
2   Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -14%, Rev Chg QQuarterly Revenue Change % is -7.5%
3   Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -7.9%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -8.3%
4   Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -140%
0 Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -29 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -3.3%
1 Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 112%
2 Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -14%, Rev Chg QQuarterly Revenue Change % is -7.5%
3 Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -7.9%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -8.3%
4 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -140%

Market Valuation & Key Metrics

NEUES&P 500
REVENUE GROWTHPOOR
Rev LTM ($ Bil)0.9
Rev Chg Q-7.5%6.4%
Rev Chg LTM-13.8%5.4%
Rev Chg 3Y Avg80.8%5.3%
PROFITABILITYVERY POOR
Op Inc LTM ($ Bil)-0.0
CFO LTM ($ Bil)-0.1
Net Inc LTM ($ Bil)-0.1
Op Mgn LTM-3.3%18.7%
CFO/Rev LTM-7.9%20.4%
Net Inc Mgn-9.2%12.8%
VALUATIONVERY LOW
P/S0.13.2
P/CFO-0.915.5
P/FCF-0.820.6
P/E-0.823.6

NEUE Stock

   
   
   
   
   
   
   
Factor Drivers of Stock Movement
null

null
null

null
null

null

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
NEUE Return---81%-85%-3%-9%-98%
Peers Return-8%36%12%10%24%2%96%
S&P 500 Return16%27%-19%24%23%16%110%

Monthly Win Rates [3]
NEUE Win Rate-33%17%42%33%56% 
Peers Win Rate53%68%57%58%63%60% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
NEUE Max Drawdown---85%-90%-50%-37% 
Peers Max Drawdown-55%-2%-12%-18%-4%-12% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: AFL, MFC, MET, PRU, PFG.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

Unique KeyEventNEUES&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-99.6%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven27385.1%34.1%
2022 Inflation ShockTime to BreakevenTime to BreakevenNot Fully Recovered days464 days

Compare to AFL, MFC, MET, PRU, PFG


In The Past

NeueHealth's stock fell -99.6% during the 2022 Inflation Shock from a high on 6/29/2021. A -99.6% loss requires a 27385.1% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About NeueHealth (NEUE)

Better Bets than NeueHealth (NEUE)

 NEUEBetter Performance than NEUE
MetricValueIndustry (Life & Health Insurance)
Rev Chg LTM-13.8%MFC (10.0%), MET (5.9%), PRU (-0.2%), PFG (12.3%), UNM (2.0%)
Rev Chg 3Y Avg80.8%JXN (169.2%), AMBC (118.6%)
Op Mgn LTM-3.3%TRUP (6.3%), ABL (19.0%)
CFO/Rev LTM-7.9%AFL (16.0%), MFC (60.3%), MET (21.1%), PRU (1.3%), PFG (26.9%)
FCF/Rev LTM-8.3%AFL (16.0%), MFC (60.3%), MET (21.1%), PRU (1.3%), PFG (26.4%)
Total Yield-135.2%AFL (6.2%), MFC (16.9%), MET (10.9%), PRU (11.5%), PFG (12.2%)
 NEUEBetter Performance than NEUE
MetricValueAll Other Sectors
Rev Chg LTM-13.8%NVDA (71.6%), AAPL (6.0%), MSFT (15.6%), GOOGL (13.4%), AMZN (10.9%)
Rev Chg 3Y Avg80.8%NVDA (92.0%), NBIS (160.6%), IONQ (104.2%), RIVN (183.6%), BBIO (727.6%)
Op Mgn LTM-3.3%NVDA (58.1%), AAPL (31.9%), MSFT (46.3%), GOOGL (32.2%), AMZN (11.4%)
CFO/Rev LTM-7.9%NVDA (46.6%), AAPL (26.6%), MSFT (50.0%), GOOGL (39.3%), AMZN (18.1%)
FCF/Rev LTM-8.3%NVDA (43.6%), AAPL (23.5%), MSFT (26.6%), GOOGL (19.1%), AMZN (2.0%)
Total Yield-135.2%NVDA (1.8%), AAPL (2.8%), MSFT (3.3%), GOOGL (3.9%), AMZN (3.0%)
 Best Bets In Financials Sector
 NEUEDBRG OTF MTG NMIH CACC ENVA FNF ACGL APAM FI
What You Pay           
P/E-0.739.713.28.47.512.310.213.98.610.510.6
P/EBIT-1.764.79.06.45.59.97.88.97.66.15.8
What You Get           
Rev Chg Q-7.5%-102.4%1,228.5%-0.7%7.2%8.3%16.3%16.8%22.4%4.4%8.0%
Rev Chg LTM-13.8%-84.8%89.0%2.2%10.0%12.5%21.1%7.4%23.5%10.0%6.7%
Rev Chg 3Y Avg80.8%125.8%221.9%1.2%10.1%6.9%23.5%-0.7%29.8%0.2%7.5%
FCF/Rev 3Y Avg-110.1%101.2%76.2%62.2%58.8%57.1%54.7%50.8%38.4%29.0%20.7%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 21%, alpha of 9.1%, and sharpe of 0.94

Latest Trefis Analyses

TitleTopic
0DASHBOARDS 
1How Low Can NeueHealth Stock Really Go?Return

Trade Ideas

Select past ideas related to NEUE. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield09302025HLNEHamilton LaneDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-14.4%-14.4%-14.4%
CNS_9302025_Dip_Buyer_ValueBuy09302025CNSCohen & SteersDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		5.9%5.9%-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025JKHYJack Henry & AssociatesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		0.3%0.3%-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025FDSFactSet Research SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-7.7%-7.7%-7.7%
IBKR_9052025_Quality_Momentum_RoomToRun_10%09052025IBKRInteractive BrokersQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		15.0%15.0%0.0%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield09302025HLNEHamilton LaneDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-14.4%-14.4%-14.4%
CNS_9302025_Dip_Buyer_ValueBuy09302025CNSCohen & SteersDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		5.9%5.9%-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025JKHYJack Henry & AssociatesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		0.3%0.3%-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025FDSFactSet Research SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-7.7%-7.7%-7.7%
IBKR_9052025_Quality_Momentum_RoomToRun_10%09052025IBKRInteractive BrokersQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		15.0%15.0%0.0%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PRAXPraxis Precision Medicines279.1%161.2%
2INBXInhibrx Biosciences131.0%409.8%
3PUMPProPetro99.6%16.2%
4DYNDyne Therapeutics88.4%-0.0%
5VICRVicor85.4%89.2%
6CELCCelcuity74.6%503.2%
7GLUEMonte Rosa Therapeutics73.5%87.5%
8NVTSNavitas Semiconductor72.1%251.8%
9LUMNLumen Technologies70.3%94.7%
10BALYBallys63.4%4.1%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical-62.9%5106.3%
2LRNStride-53.8%-35.8%
3FMCFMC-51.0%-66.6%
4FIFiserv-48.3%-68.3%
5NFENew Fortress Energy-43.6%-91.9%
6VGVenture Global-41.7% 
7OGNOrganon-40.2%-55.0%
8VRNSVaronis Systems-39.5%-21.2%
9ITGRInteger-38.5%-52.2%
10LENZLENZ Therapeutics-37.9%5.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for NeueHealth

Financials

NEUEAFLMFCMETPRUPFGMedian
NameNeueHeal.Aflac Manulife.MetLife Prudenti.Principa. 
Mkt Price-106.8432.1579.16103.0982.7482.74
Mkt Cap0.157.355.053.136.518.444.8
Rev LTM89016,20447,46272,07860,62015,80131,833
Op Inc LTM-29------29
FCF LTM-742,59128,60815,2297754,1723,381
FCF 3Y Avg-1,1292,99823,42413,7935,8884,0294,958
CFO LTM-702,59128,60815,2297754,2523,422
CFO 3Y Avg-1,1222,99823,42413,7935,8884,1175,002

Growth & Margins

NEUEAFLMFCMETPRUPFGMedian
NameNeueHeal.Aflac Manulife.MetLife Prudenti.Principa. 
Rev Chg LTM-13.8%-16.6%10.0%5.9%-0.2%12.3%2.8%
Rev Chg 3Y Avg80.8%-7.4%1.5%6.0%-2.8%-4.1%-0.6%
Rev Chg Q-7.5%-18.2%21.7%-1.8%-42.5%22.2%-4.7%
QoQ Delta Rev Chg LTM-1.9%-5.5%6.1%-0.4%-14.2%4.4%-1.2%
Op Mgn LTM-3.3%------3.3%
Op Mgn 3Y Avg-11.4%------11.4%
QoQ Delta Op Mgn LTM4.4%-----4.4%
CFO/Rev LTM-7.9%16.0%60.3%21.1%1.3%26.9%18.6%
CFO/Rev 3Y Avg-109.5%16.6%54.5%19.7%9.7%28.1%18.1%
FCF/Rev LTM-8.3%16.0%60.3%21.1%1.3%26.4%18.6%
FCF/Rev 3Y Avg-110.1%16.6%54.5%19.7%9.7%27.5%18.1%

Valuation

NEUEAFLMFCMETPRUPFGMedian
NameNeueHeal.Aflac Manulife.MetLife Prudenti.Principa. 
Mkt Cap0.157.355.053.136.518.444.8
P/S0.13.51.20.70.61.20.9
P/EBIT-1.716.96.17.9--7.0
P/E-0.723.59.112.415.911.712.0
P/CFO-0.922.11.93.547.14.33.9
Total Yield-135.2%6.2%16.9%10.9%11.5%12.2%11.2%
Dividend Yield0.0%2.0%5.9%2.9%5.2%3.7%3.3%
FCF Yield 3Y Avg-2,006.6%6.2%51.2%28.1%15.6%21.8%18.7%
D/E3.50.20.20.40.60.20.3
Net D/E1.1-1.2-0.2-1.7-1.3-1.5-1.2

Returns

NEUEAFLMFCMETPRUPFGMedian
NameNeueHeal.Aflac Manulife.MetLife Prudenti.Principa. 
1M Rtn--4.4%3.2%-3.9%-0.6%-0.2%-0.6%
3M Rtn-7.5%3.8%4.2%0.8%7.4%4.2%
6M Rtn-3.8%5.3%6.0%3.9%13.9%5.3%
12M Rtn--1.4%10.5%-2.1%-14.6%1.7%-1.4%
3Y Rtn-74.5%122.4%18.6%13.5%4.4%18.6%
1M Excs Rtn--5.2%0.6%-5.0%-1.6%-2.0%-2.0%
3M Excs Rtn--0.4%-3.8%-2.4%-5.7%1.3%-2.4%
6M Excs Rtn--18.0%-16.4%-15.7%-17.8%-7.8%-16.4%
12M Excs Rtn--18.3%-7.6%-19.1%-31.1%-15.5%-18.3%
3Y Excs Rtn-6.6%47.9%-54.4%-59.0%-62.0%-54.4%

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q3
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/2022
Filing Date8/7/20255/9/20253/21/202511/7/20248/13/20245/10/20243/28/202411/9/20238/9/20235/10/20233/16/202311/14/2022
Key Financials Quarterly            
Total Revenue209216233233226245293269298301228193
Net Income-10-12-3-57-59-16-230-634-113-175-669-317
EPS-2.62-2.90-1.94-8.51-8.65-3.53-30.47-81.03-15.70-23.68-88.00-41.48
Key Financials TTM            
Total Revenue TTM8909079379971,0331,1051,1611,0961,0208711,184-598
Net Income TTM-82-131-135-362-938-992-1,151-1,591-1,273-1,435-1,456-1,601
Growth Rates Quarterly            
Total Revenue Growth-7.5%-12.0%-20.6%-13.5%-24.2%-18.5%28.6%39.3%99.5%-51.0%114.7%-82.1%
Net Income Growth82.9%26.2%98.8%90.9%48.0%90.9%65.7%-100.1%58.9%10.4%17.9%-5.4%
Margins Quarterly            
Net Income Margin-4.8%-5.4%-1.2%-24.6%-25.9%-6.5%-78.4%-235.3%-37.9%-58.2%-293.7%-163.9%
Cash & Debt            
Total Cash14614593119142113941141083952181,905
Total Debt21320820512011866370354304304304304
Net Debt / (Cash)68631112-24-46277240196-9186-1,601
Cash Flows Quarterly            
FCF from Operations-3-21-24-22-28-49-331-1,671-109-615123-615
Cash Flows TTM            
FCF from Operations TTM-70-96-123-430-2,080-2,160-2,727-2,273-1,216-865234-39
Returns to Shareholders Quarterly            
Dividends000000000000
Share Repurchases-0-0-0-0-0-0-0-0-0-0-0-0
Return on Invested Capital (ROIC) Quarterly            
ROIC1.4%0.3%-2.7%-1.7%-2.6%-2.1%-3.9%-3.2%-2.1%-4.7%-6.3%-10.8%
Return on Invested Capital (ROIC) TTM            
ROIC TTM-0.7%-1.7%-2.3%-2.7%-3.1%-3.1%-3.3%-4.0%-4.5%-6.1%-8.7%-12.1%

Price Behavior

NEUE Betas & Captures as of 9/30/2025

 1M2M3M6M1Y3Y
Beta-0.450.190.120.130.200.79
Up Beta-0.750.210.280.150.290.69
Down Beta-3.06-0.68-0.510.100.221.10
Up Capture14%19%6%7%8%4%
Bmk +ve Days13233574144420
Stock +ve Days11213158115344
Down Capture-31%67%45%20%-24%106%
Bmk -ve Days8192952107330
Stock -ve Days9202956118380

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
8/7/2025-1.5%-2.5%-2.3%
3/20/20258.9%36.6%32.2%
11/7/20246.4%-5.6%13.4%
8/7/2024-3.5%2.8%-1.3%
3/6/202418.1%-12.6%-25.6%
11/7/20230.9%-6.8%-15.6%
8/9/2023-12.3%-33.3%-58.0%
3/1/2023-42.0%-43.6%-75.9%
...
SUMMARY STATS   
# Positive432
# Negative91011
Median Positive7.6%4.3%22.8%
Median Negative-11.9%-15.6%-16.5%
Max Positive18.1%36.6%32.2%
Max Negative-42.0%-43.6%-75.9%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025807202510-Q 6/30/2025
3312025509202510-Q 3/31/2025
12312024321202510-K 12/31/2024
93020241107202410-Q 9/30/2024
6302024813202410-Q 6/30/2024
3312024510202410-Q 3/31/2024
12312023328202410-K 12/31/2023
93020231109202310-Q 9/30/2023
6302023809202310-Q 6/30/2023
3312023510202310-Q 3/31/2023
12312022316202310-K 12/31/2022
93020221114202210-Q 9/30/2022
6302022815202210-Q 6/30/2022
3312022512202210-Q 3/31/2022
12312021318202210-K 12/31/2021
93020211115202110-Q 9/30/2021

Insider Activity

Expand for More

 

Industry Resources

External Quote Links


Prefer one of these to Trefis? Tell us why.